Steroid withdrawal relief: new study tests hydrocortisone for exhausted patients

NCT ID NCT05193396

Recruiting now Symptom relief Sponsor: Marianne Andersen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a low dose of hydrocortisone (a cortisol-like hormone) can reduce symptoms like fatigue and dizziness in people who have recently stopped taking prednisolone for giant cell arteritis or polymyalgia rheumatica. About 100 adults aged 50 and older will receive either hydrocortisone or a placebo for 16 weeks. The goal is to see if this treatment improves quality of life during the recovery period.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADRENAL INSUFFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adrenocortical insufficiency Giant Cell Arteritis polymyalgia rheumatica temporal arteritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADRENAL INSUFFICIENCY GIANT CELL ARTERITIS (GCA) POLYMYALGIA RHEUMATICA (PMR)

Contacts and locations

Locations

Department of Endocrinology and Internal Medicine, Aarhus University Hospital
RECRUITING

Aarhus, Denmark
Department of Endocrinology, Odense University Hospital
RECRUITING

Odense, 5230, Denmark
Department of Nephrology and Endocrinology, Rigshospitalet
RECRUITING

Copenhagen, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.